SciELO - Scientific Electronic Library Online

 
vol.20 issue1Ivabradine use in patients with HFrEF in the heart failure multidisciplinary program (PIC) in a private hospital: first registration and 3-years follow up, Central American (CA) region author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Costarricense de Cardiología

Print version ISSN 1409-4142

Abstract

HINOJAR, Rocío; JIMENEZ-NATCHER, José Julio; FERNANDEZ-GOLFIN, Covadonga  and  ZAMORANO, José Luis. Segunda Publicación Nuevos anticoagulantes orales: Guía práctica para los médicos. Rev. costarric. cardiol [online]. 2018, vol.20, n.1, pp.7-21. ISSN 1409-4142.

New oral anticoagulants suppose an attractive alternative for classical vitamin K antagonists (AVKs) in stroke prevention for patients with non-valvular atrial fibrillation. Unlike AVKs, these anticoagulants do not require monitoring or dose adjustment and have favourable pharmacological properties. The lack of an effective antidote, its cost, or doubts regarding the safety of patients with advanced kidney disease may explain its slow rate of expansion. The safe and effective use of these new medications depends largely on clinical experience among the medical community. This review discusses the peculiarities of the new oral anticoagulants, providing practical and easy-to-use algorithms for their application in daily clinical practice.

Keywords : atrial fibrillation; new oral anticoagulants; stroke.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )